» Articles » PMID: 28079129

CircRNA_000203 Enhances the Expression of Fibrosis-associated Genes by Derepressing Targets of MiR-26b-5p, Col1a2 and CTGF, in Cardiac Fibroblasts

Overview
Journal Sci Rep
Specialty Science
Date 2017 Jan 13
PMID 28079129
Citations 135
Authors
Affiliations
Soon will be listed here.
Abstract

Circular RNAs (circRNAs) participate in regulating gene expression in diverse biological and pathological processes. The present study aimed to investigate the mechanism underlying the modulation of circRNA_000203 on expressions of fibrosis-associated genes in cardiac fibroblasts. CircRNA_000203 was shown upregulated in the diabetic mouse myocardium and in Ang-II-induced mouse cardiac fibroblasts. Enforced-expression of circRNA_000203 could increase expressions of Col1a2, Col3a1 and α-SMA in mouse cardiac fibroblasts. RNA pull-down and RT-qPCR assay indicated that circRNA_000203 could specifically sponge miR-26b-5p. Dual luciferase reporter assay revealed that miR-26b-5p interacted with 3'UTRs of Col1a2 and CTGF, and circ_000203 could block the interactions of miR-26b-5p and 3'UTRs of Col1a2 and CTGF. Transfection of miR-26b-5p could post-transcriptionaly inhibit expressions of Col1a2 and CTGF, accompanied with the suppressions of Col3a1 and α-SMA in cardiac fibroblasts. Additionally, over-expression of circRNA_000203 could eliminate the anti-fibrosis effect of miR-26b-5p in cardiac fibroblasts. Together, our results reveal that suppressing the function of miR-26b-5p contributes to the pro-fibrosis effect of circRNA_000203 in cardiac fibroblasts.

Citing Articles

MicroRNA-26b inhibits cardiac remodeling after myocardial infarction by targeting ring finger protein 6 expression.

Tang C, Su Q, Zhao H, Sui H, Liang J, Zhu L Arch Med Sci. 2025; 20(6):2009-2021.

PMID: 39967940 PMC: 11831335. DOI: 10.5114/aoms/130649.


Circular RNAs in Cardiovascular Diseases: Molecular Mechanisms, Therapeutic Advances, and Innovations.

Yuan Z, Huang S, Jin X, Li S Genes (Basel). 2024; 15(11).

PMID: 39596623 PMC: 11593509. DOI: 10.3390/genes15111423.


Circular RNAs in human diseases.

Wang Y, Zhang J, Yang Y, Liu Z, Sun S, Li R MedComm (2020). 2024; 5(9):e699.

PMID: 39239069 PMC: 11374765. DOI: 10.1002/mco2.699.


Extensive identification of genes involved in congenital and structural heart disorders and cardiomyopathy.

Spielmann N, Miller G, Oprea T, Hsu C, Fobo G, Frishman G Nat Cardiovasc Res. 2024; 1(2):157-173.

PMID: 39195995 PMC: 11358025. DOI: 10.1038/s44161-022-00018-8.


The Role of Circular RNA in the Pathogenesis of Chemotherapy-Induced Cardiotoxicity in Cancer Patients: Focus on the Pathogenesis and Future Perspective.

Joghataie P, Bakhshi Ardakani M, Sabernia N, Salary A, Khorram S, Sohbatzadeh T Cardiovasc Toxicol. 2024; 24(11):1151-1167.

PMID: 39158829 DOI: 10.1007/s12012-024-09914-w.


References
1.
Yuan W, Tang C, Zhu W, Zhu J, Lin Q, Fu Y . CDK6 mediates the effect of attenuation of miR-1 on provoking cardiomyocyte hypertrophy. Mol Cell Biochem. 2015; 412(1-2):289-96. DOI: 10.1007/s11010-015-2635-4. View

2.
Pan Z, Sun X, Shan H, Wang N, Wang J, Ren J . MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway. Circulation. 2012; 126(7):840-50. DOI: 10.1161/CIRCULATIONAHA.112.094524. View

3.
CHAO C, Chan D, Kuo A, Leder P . The mouse formin (Fmn) gene: abundant circular RNA transcripts and gene-targeted deletion analysis. Mol Med. 1998; 4(9):614-28. PMC: 2230310. View

4.
Zhang X, Wang H, Zhang Y, Lu X, Chen L, Yang L . Complementary sequence-mediated exon circularization. Cell. 2014; 159(1):134-147. DOI: 10.1016/j.cell.2014.09.001. View

5.
Bella J, Devereux R, Roman M, Palmieri V, Liu J, Paranicas M . Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). Am J Cardiol. 2001; 87(11):1260-5. DOI: 10.1016/s0002-9149(01)01516-8. View